Neural Computations for Decision-Making in Epilepsy
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Adtech Behnke-Fried micro-electrodes, Cedrus RB-844 response pad, Neurolynx electrophysiology system for decision-making in epilepsy?
Research shows that using microelectrode arrays can help predict epileptic seizures by analyzing brain signals, which may improve seizure management and treatment planning. High-density micro-electrocorticography electrode arrays have been effective in identifying microseizures, potentially aiding in more accurate localization of epileptogenic tissue for surgical interventions.12345
Is the neural computation treatment for decision-making in epilepsy safe for humans?
Research shows that the neural interfaces used in epilepsy treatments, like the Adtech Behnke-Fried micro-electrodes, have been safely used in humans and animals. Studies indicate that these devices can be used for up to two weeks in humans with minimal tissue reaction, suggesting they are generally safe for short-term use.26789
How does the treatment using Adtech Behnke-Fried micro-electrodes, Cedrus RB-844 response pad, and Neurolynx electrophysiology system differ from other epilepsy treatments?
This treatment is unique because it uses advanced technology to predict and detect seizures by recording and analyzing brain activity in real-time, allowing for timely interventions. Unlike traditional treatments that rely on continuous medication or electrical stimulation, this approach focuses on precise, data-driven responses to seizure activity.15101112
What is the purpose of this trial?
The purpose of this research is to better understand how the human brain accomplishes the cognitive task of making goal-directed decisions. These investigations are critical to better understand human cognition and to design treatments for disorders of decision making and performance monitoring.
Research Team
Adam Mamelak, MD
Principal Investigator
Cedars-Sinai Medical Center
Ueli Rutishauser, PhD
Principal Investigator
Cedars-Sinai Medical Center
John O'Doherty, PhD
Principal Investigator
California Institute of Technology
Eligibility Criteria
This trial is for individuals aged 13 or older with intractable epilepsy who are undergoing invasive monitoring. Participants must be able to understand and perform tasks using a computer response pad, and have an IQ over 70. Those unable to complete the tasks due to cognitive, psychological limits, or pain cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Behavioral Testing
Participants undergo behavioral and neuronal recordings to assess decision-making processes
Follow-up
Participants are monitored for safety and effectiveness after the main testing phase
Treatment Details
Interventions
- Adtech Behnke-Fried micro-electrodes
- Cedrus RB-844 response pad
- Neurolynx electrophysiology system
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cedars-Sinai Medical Center
Lead Sponsor
California Institute of Technology
Collaborator
National Institute of Mental Health (NIMH)
Collaborator